Market Performance
The stock market today saw Cohance Life share price come under intense pressure. On September 18, shares of the company tumbled 6%, slipping to ₹909 apiece in early trade. The sudden slide came right after a massive block deal, which sparked heavy activity on the counters.
Main News – Heavy Block Deal Activity
A total of 3.39 crore shares of Cohance Lifesciences changed hands on the exchanges.
- This accounted for 8.9% of the company’s equity.
- The overall deal value was pegged at nearly ₹3,073 crore.
While the identity of the sellers was not confirmed, market reports suggested that a significant investor offloaded the stake. Additionally, the deal came with a 210-day lock-up period on further share sales, restricting any immediate fresh supply of shares in the market.
The size and timing of this trade created a wave of nervousness among investors, resulting in the sharp dip in the Cohance Life share price.
Company Details – Financial Snapshot
Even with the stock facing near-term selling pressure, Cohance Lifesciences’ recent financial performance sheds light on its business trajectory.
For Q1FY26, the company reported:
- Net Profit: ₹62.9 crore, down 24.8% YoY compared to ₹83.5 crore in Q1FY25.
- Revenue from Operations: ₹549.3 crore, up 12.5% YoY, supported by broad-based growth.
- Material Margin: ₹401.2 crore, marking a 20.1% YoY increase.
- Margin Percentage: Expanded to 73% from 68.4% YoY, aided by a better business mix and acquisitions.
These figures highlight that while profitability faced pressure, operational revenues and margins reflected resilience, driven by a stronger portfolio and scale benefits.
Summary
To sum up:
- Cohance Life share price dropped 6% to ₹909 after a ₹3,073 crore block deal.
- 3.39 crore shares (8.9% equity) exchanged hands in the deal.
- A 210-day lock-up has been placed on further stake sales.
- On the earnings front, Q1FY26 showed higher revenues and improved margins, though net profit slipped year-on-year.
The market reaction today reflects the immediate pressure from the large transaction, but the company’s operational numbers paint a picture of ongoing growth momentum despite short-term volatility.
